We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.4B
AUM Growth
+$3.53B
(+32%)
Cap. Flow
+$2.81B
Cap. Flow
% of AUM
19.5%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
1,820
New
468
Increased
1,221
Reduced
109
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$116M |
| 3 |
Amazon
AMZN
|
+$84.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$57.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.3M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$6.62M |
| 3 |
VF Corp
VFC
|
+$4.38M |
| 4 |
W.W. Grainger
GWW
|
+$3.97M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.64% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 13.98% |
| 4 | Consumer Staples | 10.45% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1076
DELISTED
Epizyme, Inc
EPZM
| $560K | ﹤0.01% |
44,597
+8,830
| +25% | +$128K |
|
1077
Palo Alto Networks
PANW
$264B
| $559K | ﹤0.01% |
23,142
+4,680
| +25% | +$114K |
|
|
RDC
1078
DELISTED
Rowan Companies Plc
RDC
| $559K | ﹤0.01% |
35,671
+10,856
| +44% | +$153K |
|
1079
Wolverine World Wide
WWW
$1.54B
| $558K | ﹤0.01% |
17,516
+8,818
| +101% | +$254K |
|
1080
Darling Ingredients
DAR
$9.93B
| $557K | ﹤0.01% |
30,707
+15,302
| +99% | +$264K |
|
1081
New York Times
NYT
$11.6B
| $557K | ﹤0.01% |
30,104
+12,888
| +75% | +$239K |
|
1082
Aecom
ACM
$9.07B
| $556K | ﹤0.01% |
14,959
+4,061
| +37% | +$148K |
|
|
INVX
1083
Innovex International
INVX
$1.87B
| $556K | ﹤0.01% |
11,652
+3,556
| +44% | +$159K |
|
1084
Gentex
GNTX
$4.88B
| $554K | ﹤0.01% |
26,438
+7,090
| +37% | +$141K |
|
|
IMGN
1085
DELISTED
Immunogen Inc
IMGN
| $552K | ﹤0.01% |
+86,076
| New | +$531K |
|
|
LKFT
1086
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $551K | ﹤0.01% |
+5,875
| New | +$556K |
|
1087
Bio-Rad Laboratories Class A
BIO
$8.42B
| $550K | ﹤0.01% |
2,304
+527
| +30% | +$128K |
|
1088
Neogen
NEOG
$2.05B
| $549K | ﹤0.01% |
17,792
+9,005
| +102% | +$273K |
|
|
STMP
1089
DELISTED
Stamps.com, Inc.
STMP
| $549K | ﹤0.01% |
2,920
+1,525
| +109% | +$295K |
|
|
VR
1090
DELISTED
Validus Hold Ltd
VR
| $547K | ﹤0.01% |
11,659
+710
| +6% | +$35.1K |
|
1091
Axalta
AXTA
$7.01B
| $546K | ﹤0.01% |
16,866
+3,738
| +28% | +$118K |
|
1092
Huntsman Corp
HUN
$2.24B
| $545K | ﹤0.01% |
16,367
+3,560
| +28% | +$109K |
|
1093
Marriott Vacations Worldwide
VAC
$3.24B
| $542K | ﹤0.01% |
4,006
+1,920
| +92% | +$253K |
|
|
PRA
1094
DELISTED
ProAssurance
PRA
| $541K | ﹤0.01% |
9,470
+1,028
| +12% | +$60K |
|
|
SUM
1095
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $541K | ﹤0.01% |
17,514
+9,452
| +117% | +$284K |
|
1096
Trinity Industries
TRN
$2.97B
| $539K | ﹤0.01% |
19,996
+5,392
| +37% | +$135K |
|
1097
NCR Voyix
VYX
$1.06B
| $535K | ﹤0.01% |
25,664
+6,185
| +32% | +$126K |
|
|
CVG
1098
DELISTED
Convergys
CVG
| $533K | ﹤0.01% |
22,696
+9,784
| +76% | +$242K |
|
1099
Popular Inc
BPOP
$11B
| $532K | ﹤0.01% |
14,978
+866
| +6% | +$29.9K |
|
|
DNKN
1100
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $530K | ﹤0.01% |
8,221
+2,060
| +33% | +$120K |
|
Similar funds
ProShare Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ProShare Advisors held 1,820 positions worth $14.4B, up 32% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors deployed $2.81B of net new capital in Q4 2017, opening 468 new positions and adding to 1,221 existing holdings. Its largest new stake was ASML: 31,220 shares worth $5.43M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VF Corp, an estimated $4.38M trimmed.
- ProShare Advisors's largest Q4 2017 buy was ASML: 31,220 shares worth $5.43M.
- ProShare Advisors added most to Apple in Q4 2017, an estimated $160M increase.
- ProShare Advisors's biggest Q4 2017 reduction was VF Corp, cutting an estimated $4.38M.
- ProShare Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.3M.
- ProShare Advisors's ten largest holdings make up 18% of its $14.4B portfolio in Q4 2017.
- ProShare Advisors opened 468 new positions and closed 21 in Q4 2017.
- ProShare Advisors's portfolio value rose 32% quarter-over-quarter to $14.4B.
Based on ProShare Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.